Combination Therapy

Abstract

The present invention relates to methods for treating and/or preventing metabolic diseases comprising the combined administration of a GLP-1 receptor agonist and a DPP-4 inhibitor.


Claims
Download PDF
Document Preview
Document History
  • Publication: Mar 28, 2017
  • Application: Oct 2, 2015
    US US 201514873579 A
  • Priority: Oct 2, 2015
    US US 201514873579 A
  • Priority: Dec 13, 2012
    US US 201213695492 A
  • Priority: May 5, 2011
    EP EP 2011057256 W
  • Priority: Feb 21, 2011
    EP EP 11155154 A
  • Priority: May 5, 2010
    EP EP 10162036 A

Download Citation


Sign in to the Lens

Feedback